How often should atenolol be dosed for perioperative ß-blockade?

Anesthesiology

Volumn 115, Issue 5, 2011, Pages 1140-

  Badgett, Robert G ^a   Lawrence, Valerie A ^b   Cohn, Steven L ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; METOPROLOL;

BETA ADRENERGIC RECEPTOR BLOCKING; DOSAGE SCHEDULE COMPARISON; EXERCISE; HUMAN; LETTER; MULTICENTER STUDY (TOPIC); PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 80054976302     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318233070c     Document Type: Letter

References (11)

1. Wallace AW, Au S, Cason BA: Perioperativeβ-blockade: Atenolol is associated with reduced mortality when compared to metoprolol. Anesthesiology 2011; 114:824-36
2. Badgett RG, Lawrence VA, Cohn SL: Variations in pharmacology ofβ-blockers may contribute to heterogeneous results in trials of perioperativeβ-blockade. Anesthesiology 2010; 113:585-92
3. Redelmeier D, Scales D, Kopp A: βblockers for elective surgery in elderly patients: Population based, retrospective cohort study. BMJ 2005; 331:932
4. Kaplan NM, Lieberman E: Treatment of Hypertension: Drug Therapy, Clinical Hypertension, 5th edition. Edited by Kaplan NM. Baltimore, Williams & Wilkins, 1990: 220
5. Kaplan NM, Lieberman E: Treatment of Hypertension: Drug Therapy, Clinical Hypertension, 6th edition. Edited by Kaplan NM. Baltimore, Williams & Wilkins, 1994: 225
6. Sarafidis P, Bogojevic Z, Basta E, Kirstner E, Bakris GL: Comparative efficacy of two differentβ-blockers on 24-hour blood pressure control. J Clin Hypertens (Greenwich) 2008; 10:112-8
7. Neutel JM, Schnaper H, Cheung DG, Graettinger WF, Weber MA: Antihypertensive effects ofβ-blockers administered once daily: 24-hour measurements. Am Heart J 1990; 120: 166-71 (Pubitemid 20210241)
8. Freestone S, Lennard MS, Silas JH, Ramsay LE: Duration ofβ-blockade with metoprolol and atenolol: Influence of drug oxidation. Postgrad Med J 1983; 59(Suppl 3):36-7 (Pubitemid 13022211)
9. Silas JH, Freestone S, Lennard MS, Ramsay LE: Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients. Br J Clin Pharmacol 1985; 20:387-91 (Pubitemid 16236897)
10. Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW, INVEST Investigators: A calcium antagonist versus a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial. JAMA 2003; 290:2805-16 (Pubitemid 37509488)
11. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, Miller D, Mangano DT: Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998; 88:7-17 (Pubitemid 128721126)